Advanced Filters
noise

Tokyo and Other Japanese City, Japan Clinical Trials

A listing of Tokyo and Other Japanese City, Japan clinical trials actively recruiting patients volunteers.

Found 65,447 clinical trials
A Aleah A Montano, MA

Adolescent Screening and Personalized Intervention Resource for Enhancement of Behavioral Health and Substance Use

Only a small fraction of youth who are beginning to experience behavioral health problems and use alcohol or illicit drugs receive needed treatment services due to the lack of accessible, effective early intervention resources. The goal of this clinical trial is to compare a personalized brief web-based early intervention, eHealth …

12 years of age All Phase N/A
S Shawnika Hull, PhD

Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)

In this project, the investigators will provide a new HIV prevention training and empowerment sessions to Black women in Washington D.C. who are at high risk for getting HIV. This training is tailored to the experience of Black women and seeks to reduce the high HIV transmission rates in the …

18 years of age Female Phase N/A
L Leland Metheny, MD

LMY-920 for Treatment of Relapsed or Refractory Myeloma

Since CAR-T cell treatment of refractory myeloma has shown success, based on preclinical data, we posit that CAR-T cells expressing B-cell activating factor (BAFF) can become another strategy to treat refractory myeloma, even after relapse following BCMA targeting CAR-T cell treatment. This will be phase 1 study of BAFF ligand …

18 years of age All Phase 1
E Erika Hanami

Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study

The goal of this clinical trial is to learn the effects of baricitinib (the study drug) in patients with Oral Lichen Planus. The main questions it aims to answer are: What is the efficacy of baricitinib in treating moderate to severe Oral Lichen Planus? Can baricitinib treatment in Oral Lichen …

18 years of age All Phase 2
A Armelle LEFRANCOIS

Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk

Coagulation is a complex system which, through the action of thrombin, leads to the formation of fibrin, which stabilises the platelet clot. Any disturbance in the balance between procoagulant and anticoagulant factors can tip the physiological process either towards a state of hypercoagulability leading to thrombosis or hypocoagulability responsible for …

18 years of age All Phase N/A
J Josephine Egan, M.D.

Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial

Background As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and levels of blood glucose (sugar) rise. This can lead to illnesses such as diabetes. Urolithin A (UA) is a natural nutritional supplement that may improve how the body controls blood …

55 - 100 years of age All Phase N/A
G Genying Zhuang, Master

Application of Concentrated Growth Factors in Alveolar Ridge Preservation

To explore the role of CGF in the regeneration or preservation of soft and hard tissues during tooth extraction site preservation surgery.

25 - 45 years of age All Phase N/A
E Eric SENNEVILLE, Pr

Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements

Osteoarticular infections associated with hip and knee prostheses require optimal surgical and medical management to maximize the rate of therapeutic success. Antibiotic therapy should be administered for a period of 12 weeks. Tolerance problems, difficulties in maintaining compliance over 12 weeks, bacterial multidrug resistance and sometimes intravenous administration are the …

18 years of age All Phase N/A
K Karen Hirschman, PhD, MSW

iCare4Me Transitions

The goal of this randomized controlled trial is to examine the effect of a virtual face-to-face health coach intervention to improve self-care among caregivers of hospitalized older adults during care transitions compared to web-based resource information alone to determine the effectiveness of each intervention. The main questions it aims to …

18 years of age All Phase 3
C Chun-Feng Liu, Ph.D, MD

A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease

A safety study in patients with Parkinson's disease.

45 - 70 years of age All Phase N/A

Simplify language using AI